+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-08-07Number of Pages: 189

Assisted Reproductive Technology Market (Technology - In Vitro Fertilization, Artificial Insemination, Surrogacy; Procedures - Frozen Donor, Frozen Non Donor, Fresh Donor, Fresh Non Donor, Embryo Banking; End User - Fertility Clinics, Hospitals) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Assisted Reproductive Technology Market: Snapshot

The assisted reproductive technology market comprises various medical procedures used to help conception and reduce the chances of abnormalities in the ensuing pregnancy. The market has picked up steam in recent years due to the rising prevalence of infertility and related conditions and the rising disposable income of consumers, which is allowing an increasing number to obtain medical solutions. The increasing social acceptance of assisted reproductive technology has also aided the global market for the same, which is likely to exhibit rapid progress in the coming years.

global assisted reproductive technology market

In Vitro Fertilization Likely to Lead Assisted Reproductive Technology Market

By technology, the global assisted reproductive technology market is segmented into in vitro fertilization, surrogacy, artificial insemination, and others. In vitro fertilization accounted for more than 62% of the global assisted reproductive technology market in 2016 and is likely to retain a dominant share in the coming years thanks to the rising number of citizens who are aware of the ease and efficacy of in vitro fertilization procedures. In vitro fertilization is further segmented into intra-cytoplasmic sperm injection (ICSI), and preimplantation genetic diagnosis (PGD). Preimplantation genetic diagnosis is likely to play an important role in the growth of the global assisted reproductive technology market in the coming years, due to the rising amount of information available on the risk of congenital genetic disorders and their treatment.

Based on procedure, the assisted reproductive technology market is segmented into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking. Of these, the fresh non donor segment is likely to dominate the global assisted reproductive technology market in the coming years. The segment held a majority share of 51.8% in the global assisted reproductive technology market in 2016. It benefits primarily from the desire of most parents to have children with their own genetic makeup rather than having another person involved at any stage.

Geographically, the global assisted reproductive technology market is led by Europe. The market accounted for 35% of the global assisted reproductive technology market in 2016 and is likely to remain the outright leader in the coming years despite growing demand from Asia Pacific. North America is also likely to remain a key contributor to the global assisted reproductive technology market in the coming years due to the growing prevalence of reproductive conditions in the region.

Rising Demand for Fertility Clinics Aids Growth of Assisted Reproductive Technology Market

One of the key drivers for the global assisted reproductive technology market is the rising number of fertility clinics in developing regions and the gradual lifting of the social taboos around the topic. Though developed countries remain by far the leading contributors to the global assisted reproductive technology market, developing regions such as Asia Pacific are likely to emerge as key markets for assisted reproductive technology in the coming years.

The assisted reproductive technology market has also been boosted by the rising demand from same-sex couples. The growing demand for legalization of same-sex relationships in various regions is thus likely to be a crucial driver for the global assisted reproductive technology market in the coming years.

Key players in the global assisted reproductive technology market include Merck, CooperSurgical, Inc., Irvine Scientific, Vitrolife AB, Hamilton Thorne, Inc., Nidacon International AB, Laboratoire CCD, Planer PLC, Esco Micro Pte. Ltd. (Esco Group), and Nikon Corporation. Merck holds a dominant share in the global assisted reproductive technology market due to its widespread portfolio.

Global Assisted Reproductive Technology Market: Overview

The report on the assisted reproductive technology market analyzes the current and future scenario of the global market. Increase in prevalence of infertility, advent of new technology for development of new devices for ARdT procedure for high success rate, and increase in adoption and awareness for IVF and surrogacy, are the major drivers of the global assisted reproductive technology market.

The assisted reproductive technology market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global assisted reproductive technology market with respect to the segments based on technology, procedures, end users and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global assisted reproductive technology market.

Global Assisted Reproductive Technology Market: Segmentation

Based on technology type, the assisted reproductive technology market is segmented as in vitro fertilization, artificial insemination, surrogacy and others. The in vitro fertilization is further segmented into intra-cytoplasmic sperm injection (ICSI), and preimplantation genetic diagnosis (PGD). The artificial insemination is segmented into intrauterine insemination (IUI), and intracervical insemination (ICI) and others. The technology market segments have been analyzed based on available approved technology and devices, cost-effectiveness, and preference for technology and procedures by physicians and embryologists. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on procedures, assisted reproductive technology market is segmented into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking. Based on end user, assisted reproductive technology market is segmented into fertility clinics, hospitals and others. The market segments have been extensively analyzed based on demand for technology and procedure, success rate of procedure and available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Assisted Reproductive Technology Market: Geographical and Competitive Dynamics

Geographically, the global assisted reproductive technology market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global assisted reproductive technology market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck KGaA, CooperSurgical, Inc., Irvine Scientific, Vitrolife AB, Hamilton Thorne, Inc., Nidacon International AB, Laboratoire CCD, Planer PLC, Esco Micro Pte. Ltd. (Esco Group), Nikon Corporation and others

The Global Assisted Reproductive Technology Market is segmented as given below:

Global Assisted Reproductive Technology Market, by Technology

  • In Vitro Fertilization
    • Intra-cytoplasmic Sperm Injection (ICSI)
    • Preimplantation Genetic Diagnosis (PGD)
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
    • Others
  • Surrogacy
  • Others

Global Assisted Reproductive Technology Market, by Procedure

  • Frozen Donor
  • Frozen Non Donor
  • Fresh Donor
  • Fresh Non Donor
  • Embryo Banking

Global Assisted Reproductive Technology Market, by End User

  • Fertility Clinics
  • Hospitals
  • Others

Global Assisted Reproductive Technology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Russia
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top